➤ Study: ocular manifestations of Mpox ➤ ‘World’s first’ spiral IOL designed with artificial intelligence ➤ First-in-human implantation of wireless IOP sensor ➤ Final patient visit for Phase 2 wet AMD treatment trial ➤ Enrollment, dosing complete for Phase 1 AMD, DME therapy ➤ ASCRS news and events
➤ Topline results from trial for biologic eye drop for dry eye ➤ First patient dosed in Phase 3 trial evaluating oral non-opioid sedation ➤ First patient dosed in retinitis pigmentosa gene therapy trial ➤ Clinical program for IOP-lowering drug discontinued ➤ ASCRS news and events
One physician shared how switching out the typical top on a glaucoma medication for the Nanodropper Adaptor, a screw-on cap that delivers a smaller drop of the medication, has helped her glaucoma patients from a compliance standpoint.
Two physicians provided their thoughts on diagnosis of normal tension glaucoma, establishing true progression, and how to manage worsening disease in this patient population
Glaucoma specialists have now had the opportunity to come into the 21st century alongside some of the physicians in other medical specialties who have long used home monitoring devices to collect information on their patients’ conditions to better inform treatment.
This article recaps the 2023 Richard L. Lindstrom, MD, Lecture, titled “Glaucoma Surgery: Taking it to the Next Level,” given by Marlene Moster, MD, as well as the other presentations in the session, given by Cathleen McCabe, MD, Francis Mah, MD, and Daniel Chang, MD.
➤ FDA approves ophthalmic spray for mydriasis ➤ FDA accepts NDA for travoprost intraocular implant ➤ FDA accepts supplemental BLA for treatment for macular edema ➤ FDA 510(k) clearance granted to green pattern laser photocoagulator ➤ NDA submitted for pain and inflammation nanoemulsion ➤ Positive clinical results from IOP-monitoring contact lens ➤ Study provides real-world data comparing MIGS using IRIS Registry ➤ FDA approves IOL positioning system ➤ ASCRS news and events
MIGS procedures have become a mainstay in the treatment of mild to moderate glaucoma, but what pressures can physicians realistically expect with these? Three surgeons spoke about this, as well as how MIGS can fit into the overall glaucoma management process and what to do if MIGS procedures don’t achieve the desired IOP.
Glaucoma Editor Manjool Shah, MD, talks about what readers can expect in the Glaucoma section of the issue, as well as the value of ASCRS and the Annual Meeting. He also welcomes the newest members of the Glaucoma Editorial Board.
Two physicians shared their reasons for and experiences with combining MIGS procedures.
Get the latest ophthalmology news delivered to your inbox every Friday.